Contraindications to Diclofenac
Diclofenac is absolutely contraindicated in patients undergoing coronary artery bypass graft (CABG) surgery, those with known hypersensitivity to diclofenac or other NSAIDs, and patients with a history of aspirin-sensitive asthma or allergic-type reactions to NSAIDs 1.
Absolute Contraindications
The FDA drug label clearly defines the following as absolute contraindications 1:
1. Perioperative CABG Surgery
- Do not use diclofenac for treatment of perioperative pain in the setting of CABG surgery
- This carries a black box warning due to increased cardiovascular thrombotic events 1
2. Hypersensitivity Reactions
- Known hypersensitivity to diclofenac or any drug product components
- Includes patients who have experienced anaphylactic reactions or serious skin reactions (Stevens-Johnson Syndrome, toxic epidermal necrolysis, exfoliative dermatitis) to diclofenac 1
3. Aspirin-Sensitive Asthma
- History of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs
- These patients can experience severe, sometimes fatal anaphylactic reactions
- This includes the aspirin triad: chronic rhinosinusitis with nasal polyps, severe bronchospasm, and NSAID intolerance 1
Cardiovascular Contraindications (European Regulatory Standards)
While the FDA labels these as warnings rather than absolute contraindications, European regulatory authorities established cardiovascular disease as contraindications in 2013 2, 3. These include:
- Congestive heart failure (NYHA class II-IV)
- Ischemic heart disease (including prior myocardial infarction)
- Peripheral arterial disease
- Cerebrovascular disease (including prior stroke)
Critical Context on Cardiovascular Risk
Diclofenac carries particularly high cardiovascular risk compared to other NSAIDs. The evidence shows 4:
- Vascular events: RR 1.63 (95% CI: 1.12-2.37) vs placebo
- Cardiovascular events/MI: RR 1.40 (95% CI: 1.16-1.70)
- Recurrent MI: RR 1.54 (95% CI: 1.23-1.93)
- Mortality: RR 2.40 (95% CI: 2.09-2.80)
These risks are among the highest of all NSAIDs, approaching those of selective COX-2 inhibitors.
Pregnancy Contraindications
Avoid diclofenac at ≥30 weeks gestation due to risk of premature closure of fetal ductus arteriosus 1.
Use with extreme caution at ≥20 weeks gestation due to risk of fetal renal dysfunction, oligohydramnios, and neonatal renal impairment 1.
Relative Contraindications/High-Risk Situations
The following warrant avoiding diclofenac unless benefits clearly outweigh risks 1:
- Severe heart failure - monitor closely if used
- Advanced renal disease - may hasten progression of renal dysfunction
- Active peptic ulcer disease or GI bleeding history - elderly patients at particularly high risk
- Hepatic impairment - increased risk of renal toxicity
- Dehydration or hypovolemia - correct volume status before initiating
Important Clinical Pitfalls
Despite clear regulatory warnings established in 2013, research demonstrates that more than 1 in 10 patients initiated on diclofenac have cardiovascular contraindications 3. Studies from multiple European countries show continued prescribing to patients with contraindications, suggesting limited real-world impact of risk minimization measures 5, 2, 3.
Key takeaway: The high cardiovascular mortality risk (RR 2.40) combined with evidence showing diclofenac offers no superior efficacy over safer alternatives means it should rarely be a first-line choice, particularly in patients with any cardiovascular risk factors.